Clinical Trial

REACT - Resistance Exercise After Cancer Treatment

Study acronym: REACT
Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated June 1, 2026 (before its estimated June 15, 2026 completion). Its status may not reflect the trial's current state.
Summary
Resistance exercise has been shown to improve several important health variables after cancer and cancer related treatment, but unfortunately the adherence to resistance exercise is low. Typical reported exercise barriers are inconvenient location (e.g. long distance from home), exercise at an unfavorable time of the day, inadequate access to cancer-specific exercise and insufficient recommendations from healthcare providers. Thus, there is need for more research on resistance exercise with an alternative approach in cancer rehabilitation, that potentially can target a broad range of patients, despite their domicile. In Norway, the foundation "Active against cancer" has established exercise locations targeting cancer patients in several hospitals, and today they also offer digital home-based exercise sessions. Therefore, the overall research objectives are to compare the efficacy of a 12 weeks digital, home-based resistance exercise program for cancer patients after treatment on functional, mental, and metabolic health, compared to the same program conducted in a studio under guidance of an instructor. The primary aim is to compare the effect on exercise adherence between digital home-based exercise program and the on-site guided program in cancer patients after treatment. Secondary aims are to compare the two groups on several functional health outcomes, mental health outcomes and metabolic health markers. In addition to the randomized controlled trial, the project includes two non-randomized cohorts - patients undergoing active cancer treatment, and patients living more than 20 km from an exercise location - who follow the digital home-based program and the same test protocol.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-08-29.
Status change: Recruiting → Active, Not Recruiting 2026-05-27
Trial Details
NCT Number NCT07159815
Lead Sponsor Inland Norway University of Applied Sciences
Collaborators: Sykehuset Innlandet HF
Conditions Cancer
Enrollment 160 participants
Start Date 2023-08-01
Primary Completion 2026-06-15 (estimated)
Study Completion 2028-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-06-01